All lobbying filings

FORBES-TATE

FORBES-TATE filed a Q2 report for HALOZYME THERAPEUTICS, INC. on July 20, 2026, reporting $80,000 in lobbying income.

Lobbying for HALOZYME THERAPEUTICS, INC. · U.S. Biotechnology Company

All filings by FORBES-TATE · Everything HALOZYME THERAPEUTICS, INC. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$80,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medicare/Medicaid

Issues related to coverage and reimbursement.

Issues related to biopharmaceutical research, development, and manufacturing.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem